Belviq Weight Loss Drug Arrives in Pharmacies After Receiving FDA Approval Last Year
Posted on June 11, 2013
A weight loss drug named Belviq (lorcaserin) is arriving on the market after being approved by the FDA last year. It is the first new weight loss drug on the market in over ten years.
The drug reportedly produces only minor results. The L.A. Times reports that a study found people lost an average of 3% to 3.7% of their total body weight during a year on average. A list of possible side effects can be found on drugs.com. Some of the side effects can be neurological because the drug stimulates serotonin receptors in the brain to make you feel fuller.
CBS News medical contributor Dr. Holly Phillips says headache, dizziness, fatigue and nausea are some of the more common possible side effects. Take a look:
More from Science Space & Robots
- Fossil of Giant Freshwater Turtle Discovered
- Hubble Observes Stormy Weather on Jupiter
- Australian Spider Named After Marvel's Venom
- NASA's JWST Captures New Views of NGC 604
- Ancient Giant Sea Lizard Had Dagger-Like Teeth